Joseph De Rutte

CEO, Partillion Bioscience

Joseph De Rutte is listed as CEO, Partillion Bioscience. Joseph is scheduled to speak at SLAS 2027 International Conference & Exhibition on 2 February 2027.

Compiled from published conference agendas; not yet confirmed by Joseph. Is this you? Claim this profile.

About

Dr. Joe de Rutte is Co-Founder and CEO of Partillion Bioscience, a venture-backed startup commercializing the nanovial technology he pioneered during his PhD. The impact of this work was recognized by leaders in the field and he was awarded the top Innovation Award at SLAS 2020, and New Product Award in 2022. Nanovials act as millions of suspendable wells enabling researchers to perform a range of complex single-cell and molecular assays utilizing existing lab infrastructure. Current applications include antibody discovery by single B cell screening, TCR discovery, cell line development, and linked secretion and transcriptomic analysis.

Upcoming

SLAS 2027 International Conference & Exhibition 30 January 2027 – 3 February 2027

Mapping Cell-Cell Communication from Defined Interacting Pairs with Cell-Cell-Seq Speaker · 2 February 2027